Acceder Registro /

Francisca FERRER MARÍN

Buscador

Ferrer F, Moraleda JM, Vicente V. Antithrombotic therapy after coronary-artery stenting. N Engl J Med. 1999 Apr 29;340(17):1365; author reply 1367. PubMed PMID: 10223873.
AÑO: 1999; IF: 31.736
Ferrer-Marín F, Amigo ML, Vicente V. Leukaemic transformation in patients with haematological disease receiving tumour necrosis factor inhibitors. Clin Drug Investig. 2012 Jun 1;32(6):423-6. doi: 10.2165/11599850-000000000-00000. PubMed PMID: 22550963.
AÑO: 2012; IF: 1.915
Ferrer-Marín F, Bellosillo B, Martínez-Avilés L, Soler G, Carbonell P, Luengo-Gil G, Caparrós E, Torregrosa JM, Besses C, Vicente V. Leukemic transformation driven by an ASXL1 mutation after a JAK2V617F-positive primary myelofibrosis: clonal evolution and hierarchy revealed by next-generation sequencing. J Hematol Oncol. 2013 Sep 8;6:68. doi: 10.1186/1756-8722-6-68. PubMed PMID: 24011025; PubMed Central PMCID: PMC3847205.
AÑO: 2013; IF: 11.059
González-Conejero R, Corral J, Roldán V, Martínez C, Marín F, Rivera J, Iniesta JA, Lozano ML, Marco P, Vicente V. A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients. Blood. 2002 Sep 15;100(6):2081-6. PubMed PMID: 12200370.
AÑO: 2002; IF: 9.631
Martínez C, Antón AI, Bernal A, Lozano ML, Ferrer-Marin F, Corral J, Iniesta JA, Vicente V, Rivera J. Evaluation of Novel Platelet Polymorphisms in Stroke. Dichotomic Effect of rs5443 in GNB3. J Clin Neurol. 2015 Jan;11(1):102-3. doi: 10.3988/jcn.2015.11.1.102. PubMed PMID: 25628745; PubMed Central PMCID: PMC4302171.
AÑO: 2015; IF: 2.439

Instituto de Investigación Sanitaria Acreditado

ISCII

Fondo Social Europeo "El FSE Invierte en tu futuro"

Fondo Social Europeo

Sello de Calidad Europeo "HR Excellence in Research"

HRS4R